Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen

NCT05731258 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Liposomal Doxorubicin
Efficacy
Safety
Postoperative Adjuvant Treatment

Interventions

DRUG: Liposomal doxorubicin containing regimen

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University